From April 1, 2022 to June 30, 2022, the company has repurchased 1,900,000 shares, representing 2.05% for $404.73 million. With this, the company has completed the repurchase of 5,235,604 shares, representing 5.55% for $1,404.73 million under the buyback announced on December 9, 2021.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
200.4 USD | +0.09% | +1.08% | -11.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.81% | 16.88B | |
+14.61% | 81.68B | |
-29.40% | 69.23B | |
+9.72% | 29.08B | |
-0.43% | 16.85B | |
-1.02% | 15.15B | |
+3.42% | 12.62B | |
+28.98% | 12.47B | |
-30.70% | 11.89B | |
-6.12% | 11.68B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Tranche Update on Laboratory Corporation of America Holdings (NYSE: LH)'s Equity Buyback Plan announced on December 9, 2021.